GlassScriptPhysician profile
Christina Wiley
NPI 1770236077
$696.54
in general payments reported to CMS, 2019-2025
14 companies · $414 in 2025
The $414 reported for 2025 was more than what 90% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.87 · 2023: $60.85 · 2024: $205 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $114.50 | 2023-2025 | Doc Band |
| Collegium Pharmaceutical, INC. | $112.76 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $81.34 | 2022-2025 | Vaxelis, Vaxneuvance, M-M-R II |
| Supernus Pharmaceuticals, INC. | $62.64 | 2025 | Qelbree |
| Corium, LLC | $45.27 | 2025 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $43.30 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $43.26 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $41.00 | 2023-2024 | Kristalose |
| Sanofi Pasteur INC. | $38.14 | 2024 | |
| Seqirus USA INC | $32.66 | 2024-2025 | Flucelvax |
| Pfizer INC. | $23.76 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.40 | 2025 | Flumist Quadrivalent |
| Tris Pharma INC | $21.35 | 2025 | Dyanavel Xr |
| Kowa Pharmaceuticals America, INC. | $13.16 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.